Natasha Petry, PharmD, MPH, BCACP

Associate Professor of Practice
20D Sudro Hall 


Master of Public Health, 2020
North Dakota State University, Fargo, ND

Pharmacy Practice (PGY1) Residency, 2012-2013
Trinity Hospital /North Dakota State University - Minot, ND

Doctor of Pharmacy, 2012
North Dakota State University, Fargo, ND

Bachelor of Science, Pharmaceutical Sciences, 2010
North Dakota State University. Fargo, ND

Bachelor of Science, Microbiology, 2001
Minors: Chemistry, Food Safety, Biotechnology
North Dakota State University, Fargo, ND

Clinical Site 

Sanford Health Imagenetics


Associate Professor of Practice, Department of Pharmacy Practice
Co-Advisor American Pharmacists Association-Academy of Student Pharmacists
Preceptor,Pharmacogenomics Elective Clinical Clerkship
Pharmacogenomics Clinical Pharmacist and PGY2 Clinical Pharmacogenomics Residency Program Director, Sanford Health Imagenetics


Department of Pharmacy Practice Experiential Education Committee
School of Pharmacy Curriculum Committee
College of Health Professions Inclusivity Committee
Sanford Health Enterprise Pharmacogenetics Committee

Pharmacist Licensure 

North Dakota


Board Certified Ambulatory Care Pharmacist

Areas of Expertise 

  • Diabetes
  • Patient-Centered Medical Home Model
  • Pharmacogenomics
  • Ambulatory Care
  • Public Health


PHRM 340 Pathophysiology (Course Coordinator)
PHRM 534 Endocrine Therepeutics (Course Coordinator)
PHRM 580 Pharmacotherapy Capstone
PHRM 581-589 Clinical Clerkship: Pharmacogenomics
PHRM 536/636 Pharmacotherapy: Neurology/Psychiatry (Previously taught)
PHRM 189 Skills for Academic Success (Previously taught)

Professional Organization Memberships

North Dakota Society of Health-Systems Pharmacists
American Pharmacists Association
American Association of Colleges of Pharmacy
American Society of Health-System Pharmacists
American College of Clinical Pharmacists

Recent Publications

Dietz JA, Halver A, Hammer KD, Petry NJ, Westall S, Lo TS. A Narrative Review of Placebo and Nocebo Effects on Itch. J Explor Res Pharmacol. Published online: Jun 16, 2023. doi: 10.14218/JERP.2022.00090.

Massmann A, Petry NJ. Impact of transitioning to an active, noninterruptive CYP2C19/proton pump inhibitor alert on prescribing patterns. Am J Health Syst Pharm. 2023 May 8:zxad100. doi: 10.1093/ajhp/zxad100. Epub ahead of print. PMID: 37155711.

Petry NJ, Curtis B, Feldhege E, Khan S, Leedahl DD, Breidenbach JL, Hines L. Impact of Automated Best Practice Advisories on Provider Response to CYP2C19 Genotyping Results for Patients on Clopidogrel. Journal of Pharmacy Practice. 2023;36(3):487-493. doi:10.1177/08971900211049589

Van Heukelom J, Jacobsen K, Petry NJ, Schultz A, Baye J, Sturdevant D, Massmann A. Patient Satisfaction with Return of Pharmacogenomics Results Utilizing a Patient Portal Message. Pharmacogenomics. 2023. Apr 26. doi: 10.2217/pgs-2023-0032. Epub ahead of print. PMID: 37125619.

Buckley E, Gunaseelan S, Aronson BD, Anksorus HN, Belousova V, Cat TB, Cline KM, Curtis SD, DeRemer CE, Fuentes D, Grinalds MS, Haines SL, Johnson HE, Kopacek K, Louie JM, Nonyel NP, Petry N, Taylor SR, Harris SC, Sadowski CA, Law AV. Well-Being Content Inclusion in Pharmacy Education Across the US and Canada. Am J Pharm Educ. 2023; 87(3) Article 8918. DOI: 10.5688/ajpe8918. PMID: 36202422.

Lee YM, Berenbrok LA, Galvez-Peralta M, Iwuchukwu O, Kisor DF, Petry NJ, and Gammal RS. Advancing Pharmacogenomics-Based Care Through Interprofessional Education. American Journal of Pharmaceutical Education, 2023. doi:


Collett S, Massmann A, Petry NJ, Van Heukelom J, Schultz A, Hellwig T, Baye JF. Metoprolol and CYP2D6: A Retrospective Cohort Study Evaluating Genotype-Based Outcomes. Journal of Personalized Medicine. 2023; 13(3):416.

Petry NJ, Van Heukelom J, Baye JF, Massmann A. The effect of medication reconciliation on generating an accurate medication list in a pharmacogenomics practice. Ann Transl Med. 2022 Dec;10(23):1259. doi: 10.21037/atm-2022-63. PMID: 36618791.

Blout Zawatsky, C.L.; Leonhard, J.R.; Bell, M.; Moore, M.M.; Petry, N.J.; Platt, D.M.; Green, R.C.; Hajek, C.; Christensen, K.D. Workforce Considerations When Building a Precision Medicine Program. J. Pers. Med. 2022, 12, 1929.

Gunaseelan S, Aronson BD, Anksorus HN, Belousova V, Cat TB, Cline KM, Curtis SD, DeRemer CE, Fuentes D, Grinalds MS, Haines SL, Johnson HE, Kopacek K, Louie JM, Nonyel NP, Petry N, Taylor SR, Harris SC, Sadowski CA, Law AV. Well-Being Content Inclusion in Pharmacy Education Across the US and Canada. Am J Pharm Educ. 2022 Oct 6:8918. doi: 10.5688/ajpe8918. Epub ahead of print. PMID: 36202422.

Skoy E, Petry N, Richter L, Knauf T, Monahan B, Rue J. Implementation and evaluation of a student scholarship program to increase care initiatives in rural pharmacies. Curr Pharm Teach Learn. 2022 Oct;14(10):1292-1297. doi: 10.1016/j.cptl.2022.09.009. Epub 2022 Sep 15. PMID: 36283796.

Baye J, Massmann A, Petry N, Van Heukelom J, De Berg K, Schultz A, Hajek C. Development and early evaluation of clinical decision support for long QT syndrome population screening. Journal of Translational Genetics and Genomics. 2022; 6(3):375-87.

Sperber NR, Cragun D, Roberts MC, Bendz L, Ince P, Gonzales S, Haga S, Wu R, Petry N, Ramsey L, Uber R. A Mixed-Methods Protocol to Identify Best Practices for Implementing Pharmacogenetic Testing in Clinical Settings. J. Pers. Med. 2022, 12, 1313.

Petry NJ, Baye JF, Frear S, Jacobsen K, Massmann A, Schultz A, Heukelom JV, Christensen K. Progression of precision statin prescribing for reduction of statin-associated muscle symptoms. Pharmacogenomics. 2022 Jul;23(10):585-596. doi: 10.2217/pgs-2022-0055. Epub 2022 Jul 1. PMID: 35775396.

Saugstad AA, Petry N, Hajek C. Pharmacogenetic Review: Germline Genetic Variants Possessing Increased Cancer Risk With Clinically Actionable Therapeutic Relationships. Front Genet. 2022 May 24;13:857120. doi: 10.3389/fgene.2022.857120. PMID: 35685436.

Salloum RG, Bishop JR, Elchynski AL, Smith DM, Rowe E, Blake KV, Limdi NA, Aquilante CL, Bates J, Beitelshees AL, Cipriani A, Duong BQ, Empey PE, Formea CM, Hicks JK, Mroz P, Oslin D, Pasternak AL, Petry N, Ramsey LB, Schlichte A, Swain SM, Ward KM, Wiisanen K, Skaar TC, Van Driest SL, Cavallari LH, Tuteja S. Best-worst scaling methodology to evaluate constructs of the Consolidated Framework for Implementation Research: application to the implementation of pharmacogenetic testing for antidepressant therapy. Implement Sci Commun. 2022 May 14;3(1):52. doi: 10.1186/s43058-022-00300-7. PMID: 35568931.

Hajek C, Hutchinson AM, Galbraith LN, Green RC, Murray MF, Petry N, Preys CL, Zawatsky CLB, Zoltick ES, Christensen KD; Imagenetics METRICS Team. Improved provider preparedness through an 8-part genetics and genomic education program. Genet Med. 2022 Jan;24(1):214-224. doi: 10.1016/j.gim.2021.08.008. Epub 2021 Nov 30. PMID: 34906462.

Tuteja S, Salloum RG, Elchynski AL, Smith DM, Rowe E, Blake KV, Limbdi NA, Aquilante CL, Bates J, Beitelshees AL, Cipriani A, Duong BQ, Empey PE, Formea CM, Hicks JK, Mroz P, Oslin D, Pasternak AL, Petry N, Ramsey LB, Schlichte A, Swain SM, Ward KM, Wiisanen K, Skaar TC, Van Driest SL, Cavallari LH, Bishop JR, for the IGNITE Pharmacogenetics Working. Multisite evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapy. Clin Transl Sci. 2021; 00: 1– 13.

Bright DR, Petry N, Roath E, Gibb T. Engaging pharmacogenomics in pain management and opioid selection. Pharmacogenomics. 2021 Sep;22(14):927-937. doi: 10.2217/pgs-2021-0044. Epub 2021 Sep 15. PMID: 34521258.

Luzum, J.A., Petry, N., Taylor, A.K., Van Driest, S.L., Dunnenberger, H.M. and Cavallari, L.H. (2021), Moving Pharmacogenetics into Practice: It’s All About the Evidence!. Clin Pharmacol Ther. 2021 Sep;110(3):649-661. doi: 10.1002/cpt.2327.

Gammal RS, Lee YM, Petry NJ, Iwuchukwu O, Hoffman JM, Kisor DF, and Empey PE. Pharmacists Leading the Way to Precision Medicine: Updates to the Core Pharmacist Competencies in Genomics. AJPE. July 2021, 8634; DOI:

Duarte JD, Dalton R, Elchynski AL, Smith DM, Cicali EJ, Lee JC, Duong BQ, Petry NJ, Aquilante CL, Beitelshees AL, Empey PE, Johnson JA, Obeng AO, Pasternak AL, Pratt VM, Ramsey LB, Tuteja S, Van Driest SL, Wiisanen K, Hicks JK, Cavallari LH, and IGNITE Network Pharmacogenetics Working Group. Multisite investigation of strategies for the clinical implementation of pre-emptive pharmacogenetic testing. Genet Med (2021).

Bishop JR, Huang RS, Brown JT, Mroz P, Johnson SG, Allen JD, Bielinski SJ, England J, Farley JF, Gregornik D, Giri J, Kroger C, Long SE, Luczak T, McGonagle EJ, Ma S, Matey ET, Mandic PK, Moyer A, Nicholson WT, Petry N, Pawloski P, Schlichte A, Schondelmeyer S, Seifert R, Speedie M, Stenehjem D, Straka R, Wachtle J, Waring S, Van Ness B, Zierhut HA, Aliferis C, Wolf SM, McCarty CA, Jacobson PA. Pharmacogenomics education, research and clinical implementation in the state of Minnesota. Pharmacogenomics. Published online June 17, 2021. doi:10.2217/pgs-2021-0058

Stoneberg M, Petry N, Grindeland C, Roemmich M, Massmann A, Baye J and Schultz A, “Developing a Standardized Review Process of Pharmacogenomics Resources for Psychotropic Medications”, Current Pharmacogenomics and Personalized Medicine 2021; 18().

Kisor DF, Petry NJ, Bright DR. Pharmacogenomics in the United States Community Pharmacy Setting: The Clopidogrel-CYP2C19 Example. Pharmgenomics Pers Med. 2021;14:569-577.

Christensen KD, Bell M, Zawatsky CL, Galbraith LN, Green RC, Hutchinson AM, Jamal L, LeBlanc JL, Leonhard JR, Moore M, Mullineaux L, Petry N, Platt DM, Shaaban S, Schultz A, Tucker BD, Van Heukelom J, Wheeler E, Zoltick ES, Hajek C. Precision population medicine in primary care: The Sanford Chip experience.  Front. Genet., 12 March 2021

Chen AMH, Armbruster AL, Buckley B, Campbell JA, Dang DK, Devraj R, Drame I, Edwards A, Haack SL, Ma Q, Petry N, Planas LG, Sadowski CA, Santee J, Wade L, and Borja-Hart N. Curricular Inclusion of Health Disparities/Cultural Competence and Health Literacy in U.S. and Canadian Pharmacy Programs. Am J Pharm Educ. 2021 Jan;85(1) 8200; DOI:

Bright D, Petry N, Roath E, Reckow E, Chavour S. Barriers, solutions, and effect of using pharmacogenomics data to support opioid prescribing. J Manag Care Spec Pharm. 2020;26(12):1597-602

Gammal RS, Nguyen J, Audi E, Lee YM, Petry N, Empey PE. Advanced Pharmacy Practice Experiences in Pharmacogenomics Offered by US Pharmacy Programs. Am J Pharm Educ. 2020 Dec;84(12):ajpe8031. doi: 10.5688/ajpe8031. PMCID: PMC7779881.

Baye JF, Petry NJ, Jacobson SL, Moore MM, Tucker B, Shaaban S, Massmann AK, Clark NM, Schultz AJ. Malignant hyperthermia susceptibility: utilization of genetic results in an electronic medical record to increase safety. Pharmacogenomics. 2020 Nov;21(17):1207-1215. doi: 10.2217/pgs-2020-0088. Epub 2020 Oct 29. PMID: 33118445.

Petry NJ, Montgomery AD, Hammer KDP, Lo TS. Methicillin-resistant Staphylococcus aureus (MRSA) screening upon inpatient hospital admission: Is there concordance between nasal swab results and samples taken from skin and soft tissue? Infection Control & Hospital Epidemiology. 2020:1-4. doi:10.1017/ice.2020.345

Duong BQ, Arwood MJ, Hicks JK, Beitelshees AL, Franchi F, Houder JT, Limdi NA, Cook KJ, Owusu Obeng A, Petry N, Tuteja S, Elsey AR, Cavallari LH, Wiisanen K. Development of Customizable Implementation Guides to Support Clinical Adoption of Pharmacogenomics: Experiences of the Implementing GeNomics In pracTicE (IGNITE) Network. Pharmgenomics Pers Med. 2020;13:217-226

Butler L, Chen AMH, Borja-Hart N, Arif S, Armbruster A, Petry N, Riley A. Assessment of a multi-institution integration of cultural competency activities. Currents in Pharmacy Teaching and Learning 12 (2020) 517–523.

Top of page